Abstract
To develop and evaluate molecularly imprinted nanocarriers for sustained release of erythromycin in physiological buffer media.
Original language | English |
---|---|
Pages (from-to) | 375-388 |
Journal | Pharmaceutical Research |
Volume | 32 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2015 |
Subject classification (UKÄ)
- Pharmaceutical Sciences